tiprankstipranks
Phasebio Pharmaceuticals Inc (PHAS)
NASDAQ:PHAS

Phasebio Pharmaceuticals (PHAS) Cash flow

0 Followers

Phasebio Pharmaceuticals Cash Flow

PHAS's free cash flow for Q was $-10.47M. For the fiscal year, PHAS's free cash flow was decreased by $11.27M and operating cash flow was $-10.41M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Operating Cash Flow
$ -59.42M$ -47.42M$ -59.96M$ -39.59M$ -17.05M$ -8.26M
Investing Cash Flow
$ -2.40M$ -2.68M$ -1.41M$ -960.00K$ -119.00K$ -216.00K
Financing Cash Flow
$ 5.17M$ 63.77M$ 15.47M$ 53.53M$ 64.80M$ 18.17M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 124.65M$ 41.80M$ 28.12M$ 74.03M$ 61.05M$ 13.43M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ 338.00K$ 517.00K$ 954.00K$ 576.00K$ 260.00K$ 12.00K
Issuance Of Capital Stock
$ 1.92M$ 60.35M$ 2.94M$ 46.28M$ 60.69M$ 0.00
Issuance Of Debt
---$ 8.09M$ 4.00M$ 18.16M
Repayment Of Debt
$ -5.46M$ -5.46M$ -2.73M$ -938.00K$ 0.00-
Free Cash Flow
$ -61.82M$ -50.09M$ -61.37M$ -40.55M$ -17.17M$ -8.47M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Phasebio Pharmaceuticals Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis